China Resources Boya Bio-pharmaceutical Warns of Sharp 2025 Profit Slump
China Resources Boya Bio-pharmaceutical Group (CR Boya) has issued a stark profit warning for 2025, forecasting net profit attributable to shareholders at RMB105 million to RMB136.5 million—a steep